Transfusion Medicine Reviews
Volume 20, Issue 4 , Pages 273-282 , October 2006

Serious Hazards of Transfusion: A Decade of Hemovigilance in the UK

References 

  1. UK Department of Health . Health service circular. Better blood transfusion—Appropriate use of blood. HSC 2002/009 http://www.doh.gov.uk2002;
  2. EU Directive 2002/98/EC, OJ L 33, 8.2.2003, 30-40.
  3. Wells AW, Mounter PJ, Chapman CE, et al. Where does blood go? Prospective observational study of red cell transfusion in north England. Br. Med. J. 2002;325:803–804
  4. Wallis JP, Wells AW, Matthews JNS, et al. Long term survival after blood transfusion: A population based study in the north of England. Transfusion. 2004;44:1025–1032
  5. Murphy M, Howell C. Survey of the implementation of the recommendations in the Health Service Circular 2002/009 ‘Better Blood Transfusion’. Transfus. Med. 2005;15:453–460
  6. Llewellyn CA, Hewitt P, Knight RS, et al. Possible transmission of variant Creutzfeld-Jakob disease by blood transfusion. Lancet. 2004;363:417–421
  7. Pedan AH, Head MW, Ritchie DL, et al. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet. 2004;364:527–529
  8. Soldan K, Barbara JA, Ramsay ME, et al. Estimation of the risk of hepatitis B virus, hepatitis C virus and human immunodeficiency virus entering the blood supply in England, 1993-2001. Vox Sang. 2003;84:274–286
  9. Popovsky MA, Moore SB. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion. 1985;25:573–577
  10. Kopko PM. Transfusion-related acute lung injury. Br. J. Haematol. 1999;105:322–329
  11. Wallis JP, Lubenko A, Wells AW, et al. Single hospital experience of TRALI. Transfusion. 2003;43:1053–1059
  12. Serious hazards of transfusion annual report 2004. Manchester, UK. ISBN 0 9532 789 7 2.
  13. Stainsby D, Burrowes-King V. Audit of the use of FFP. http://www.blood.co.uk/HOSPITALS/library/bm/issue10/BM1004.htm
  14. Stainsby D, Knowles SM, Milkins C, et al: Can haemolytic transfusion reactions be avoided by better laboratory practice? Vox Sang. 89:14, (Suppl 1)
  15. Serious hazards of transfusion annual report 2001/2. Manchester, UK. ISBN 0 9532 789 5 6
  16. McClelland DBL. Treating a sick process. Transfusion. 1998;38:999–1003
  17. Serious hazards of transfusion annual report 2003. Manchester, UK. ISBN 0 9532 789 6 4
  18. WHO Draft guidance on adverse event reporting and learning systems. http://www.who.int/patientsafety/events/05/Reporting_Guidelines.pdf
  19. Chapman JF, Milkins CE. Sharing data as a means to improving practice. Transfus. Med. 2005;15:33;(Suppl 1)
  20. Gerrard R. A role for direct nursing input into the serious hazards of transfusion scheme. Br. J. Haematol. 2006;133:S1
  21. Stainsby D, Russell J, Cohen H. Reducing adverse events in blood transfusion. Br. J. Haematol. 2005;131:1–8

PII: S0887-7963(06)00030-7

doi: 10.1016/j.tmrv.2006.05.002

Transfusion Medicine Reviews
Volume 20, Issue 4 , Pages 273-282 , October 2006